Literature DB >> 19870084

A STUDY OF THE THERAPEUTIC MECHANISM OF ANTIPNEUMOCOCCIC SERUM ON THE EXPERIMENTAL DERMAL PNEUMOCOCCUS INFECTION IN RABBITS : I. THE PRESENCE IN ANTIPNEUMOCOCCIC SERUM OF A NON-ANTIBACTERIAL THERAPEUTIC FACTOR.

A B Sabin1.   

Abstract

1. Antipneumococcic serum contains in addition to the antibodies against the various bacterial constituents, a non-antibacterial therapeutic factor. 2. The non-antibacterial factor has been separated from the antibacterial antibodies by absorption with homologous, heat-killed, virulent pneumococci. 3. The non-antibacterial factor is not type-specific; it is probably species-specific; it is not neutralized by concentrated pneumococcus broth culture filtrate. 4. The therapeutic effect of the non-antibacterial factor was demonstrated on the experimental, dermal pneumococcus infection of rabbits; this effect is demonstrable when it is administered per seor in conjunction with a certain subeffective dose of serum. 5. Evidence is presented for the assumption that the ultimate outcome of pneumococcus infection depends to a considerable extent upon this non-antibacterial factor.

Entities:  

Year:  1932        PMID: 19870084      PMCID: PMC2132177          DOI: 10.1084/jem.56.4.531

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  THE NEUTRALIZATION OF ANTIPNEUMOCOCCUS IMMUNE BODIES BY INFECTED EXUDATES AND SERA.

Authors:  R Cole
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

2.  TOXIC SUBSTANCES PRODUCED BY PNEUMOCOCCUS.

Authors:  R Cole
Journal:  J Exp Med       Date:  1912-11-01       Impact factor: 14.307

3.  DIFFERENTIATION BETWEEN SOME TOXIC SUBSTANCES IN ANAEROBICALLY PRODUCED AUTOLYSATES OF PNEUMOCOCCI (TYPES I AND II).

Authors:  J T Parker
Journal:  J Exp Med       Date:  1929-03-31       Impact factor: 14.307

4.  AN EXAMINATION OF THE MECHANISM OF PNEUMOCOCCUS IMMUNITY BY MEANS OF BACTERICIDAL MEASUREMENTS : I. THE REACTION BETWEEN THE ANTICARBOHYDRATE ANTIBODY AND THE PURIFIED SPECIFIC CARBOHYDRATE.

Authors:  H K Ward
Journal:  J Exp Med       Date:  1932-03-31       Impact factor: 14.307

5.  THE PRODUCTION AND TITRATION OF POTENT HORSE ANTIPNEUMOTOXIN.

Authors:  J T Parker; M V McCoy
Journal:  J Exp Med       Date:  1929-06-30       Impact factor: 14.307

6.  FURTHER EXPERIMENTS WITH THE INTRADERMAL PNEUMOCOCCUS INFECTION IN RABBITS.

Authors:  K Goodner
Journal:  J Exp Med       Date:  1928-08-31       Impact factor: 14.307

7.  THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

Authors:  A R Dochez; O T Avery
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

8.  A TYPE SPECIFIC SUBSTANCE DISTINCT FROM THE SPECIFIC CARBOHYDRATE IN PNEUMOCOCCUS TYPE I.

Authors:  J F Enders
Journal:  J Exp Med       Date:  1930-07-31       Impact factor: 14.307

9.  STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : III. INCREASED RESISTANCE TO TYPE III INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R AND S FORMS OF PNEUMOCOCCUS.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1927-07-31       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.